gamma-aminobutyric acid has been researched along with Movement Disorders in 83 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment by progabide, a GABA-agonist, was successful in one case: a gradual improvement was observed during four weeks and the movements have now disappeared after six months of progabide therapy." | 5.27 | [Progabide treatment of a case of the syndrome of painful legs and moving toes]. ( Bovier, P; Hilleret, H; Tissot, R, 1985) |
"In childhood, movement disorders are generated by a very large number of disorders of the nervous system, and the very different developmental ages at which these occur make studies of pharmacotherapy efficacy extremely difficult." | 2.55 | Advances in pharmacotherapies for movement disorders in children: current limitations and future progress. ( Lin, JP, 2017) |
"Among psychiatric disorders the acute symptoms of schizophrenia are exacerbated by enhanced GABA-ergic function." | 2.36 | Pharmacology of GABA. ( Meldrum, B, 1982) |
"Stroke is a leading cause of adult disability owing largely to motor impairment and loss of function." | 1.51 | The Influence of Primary Motor Cortex Inhibition on Upper Limb Impairment and Function in Chronic Stroke: A Multimodal Study. ( Ackerley, SJ; Barber, PA; Byblow, WD; Cirillo, J; Mooney, RA; Rajeswaran, DK; Stinear, CM, 2019) |
"Gamma-aminobutyric acid (GABA) is a major modulator in brain maturation and its role in many different neurodevelopmental disorders has been widely reported." | 1.48 | Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders. ( Armstrong-Morón, J; Artuch, R; Casado, M; Cortès-Saladelafont, E; Cuadras, D; García-Cazorla, À; Molero-Luis, M; Montoya, J; Yubero, D, 2018) |
" Chronic administration of haloperidol (1 mg/kg, i." | 1.35 | Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2008) |
"These findings suggest that progressive hydrocephalus results in functional injuries of cholinergic and GABAergic neurons in the neostriatum and dopaminergic neurons in the substantia nigra compacta by mechanical distortion." | 1.30 | Functional injury of cholinergic, GABAergic and dopaminergic systems in the basal ganglia of adult rat with kaolin-induced hydrocephalus. ( Chakrabortty, S; Drake, JM; Hattori, T; Tashiro, Y, 1997) |
"Hydrocephalus was induced in 12 Wistar rats by intracisternal injection of 0." | 1.30 | Functional injury of cholinergic, GABAergic and dopaminergic systems in the basal ganglia of adult rat with kaolin-induced hydrocephalus. ( Chakrabortty, S; Drake, JM; Hattori, T; Tashiro, Y, 1997) |
"The pathophysiology of idiopathic dystonia, characterized by sustained twisting movements and postures, is still unknown." | 1.30 | Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters. ( Gernert, M; Löscher, W; Richter, A, 1999) |
" This effect which was quantified in terms of numbers of tongue protrusions, was dose-dependent: a bell-shaped dose-response was found (50-500 ng)." | 1.29 | Interactions of the subthalamic nucleus and the subpallidal area in oro-facial dyskinesia: role of GABA and glutamate. ( Cools, AR; Helfrich, SE; Spooren, WP, 1995) |
"Treatment by progabide, a GABA-agonist, was successful in one case: a gradual improvement was observed during four weeks and the movements have now disappeared after six months of progabide therapy." | 1.27 | [Progabide treatment of a case of the syndrome of painful legs and moving toes]. ( Bovier, P; Hilleret, H; Tissot, R, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (48.19) | 18.7374 |
1990's | 9 (10.84) | 18.2507 |
2000's | 19 (22.89) | 29.6817 |
2010's | 13 (15.66) | 24.3611 |
2020's | 2 (2.41) | 2.80 |
Authors | Studies |
---|---|
Feng, H | 1 |
Yuan, Y | 1 |
Williams, MR | 1 |
Roy, AJ | 1 |
Leipprandt, JR | 1 |
Neubig, RR | 1 |
Li, HQ | 1 |
Spitzer, NC | 1 |
Lin, JP | 1 |
Cortès-Saladelafont, E | 1 |
Molero-Luis, M | 1 |
Cuadras, D | 1 |
Casado, M | 1 |
Armstrong-Morón, J | 1 |
Yubero, D | 1 |
Montoya, J | 1 |
Artuch, R | 1 |
García-Cazorla, À | 1 |
Alvarado-Franco, NL | 1 |
Gonzalez-Marques, C | 1 |
Olguín-Ramírez, LA | 1 |
Garza-Alpirez, A | 1 |
Femat-Roldan, G | 1 |
Martinez-Ramirez, D | 1 |
Mooney, RA | 1 |
Ackerley, SJ | 1 |
Rajeswaran, DK | 1 |
Cirillo, J | 1 |
Barber, PA | 1 |
Stinear, CM | 1 |
Byblow, WD | 1 |
Bhattacharyya, PK | 1 |
Phillips, MD | 1 |
Stone, LA | 1 |
Bermel, RA | 1 |
Lowe, MJ | 1 |
Helmich, RC | 1 |
Toni, I | 1 |
Deuschl, G | 1 |
Bloem, BR | 1 |
Boecker, H | 1 |
Carelli, S | 1 |
Giallongo, T | 1 |
Viaggi, C | 1 |
Gombalova, Z | 1 |
Latorre, E | 1 |
Mazza, M | 1 |
Vaglini, F | 1 |
Di Giulio, AM | 1 |
Gorio, A | 1 |
Fourcade, G | 1 |
Roubertie, A | 1 |
Doummar, D | 1 |
Vidailhet, M | 1 |
Labauge, P | 1 |
Gharibzadeh, S | 1 |
Sarbaz, Y | 1 |
Banaie, M | 1 |
Towhidkhah, F | 1 |
Sherin, A | 1 |
Peeyush, KT | 1 |
Naijil, G | 1 |
Chinthu, R | 1 |
Paulose, CS | 1 |
Arinami, T | 1 |
Inada, T | 1 |
Fatemi, SH | 1 |
Aldinger, KA | 1 |
Ashwood, P | 1 |
Bauman, ML | 1 |
Blaha, CD | 1 |
Blatt, GJ | 1 |
Chauhan, A | 1 |
Chauhan, V | 1 |
Dager, SR | 1 |
Dickson, PE | 1 |
Estes, AM | 1 |
Goldowitz, D | 1 |
Heck, DH | 1 |
Kemper, TL | 1 |
King, BH | 1 |
Martin, LA | 1 |
Millen, KJ | 1 |
Mittleman, G | 1 |
Mosconi, MW | 1 |
Persico, AM | 1 |
Sweeney, JA | 1 |
Webb, SJ | 1 |
Welsh, JP | 1 |
Gittis, AH | 1 |
Kreitzer, AC | 1 |
Teo, JT | 1 |
Edwards, MJ | 1 |
Bhatia, K | 1 |
Ugawa, Y | 1 |
Hanajima, R | 1 |
Fedrowitz, M | 1 |
Lindemann, S | 1 |
Löscher, W | 2 |
Gernert, M | 2 |
Ackley, BD | 1 |
Kang, SH | 1 |
Crew, JR | 1 |
Suh, C | 1 |
Jin, Y | 1 |
Kramer, JM | 1 |
Ravizza, T | 1 |
Friedman, LK | 1 |
Moshé, SL | 1 |
Velísková, J | 1 |
BERTAMINO, F | 1 |
VENTO, R | 1 |
Ethofer, T | 1 |
Seeger, U | 1 |
Klose, U | 1 |
Erb, M | 1 |
Kardatzki, B | 1 |
Kraft, E | 1 |
Landwehrmeyer, GB | 1 |
Grodd, W | 1 |
Storch, A | 1 |
Villarejo, A | 1 |
Porta-Etessam, J | 1 |
Camacho, A | 1 |
González De La Aleja, J | 1 |
Martínez-Salio, A | 1 |
Penas, M | 1 |
de Lago, E | 1 |
Fernández-Ruiz, J | 2 |
Ortega-Gutiérrez, S | 1 |
Cabranes, A | 1 |
Pryce, G | 1 |
Baker, D | 1 |
López-Rodríguez, M | 1 |
Ramos, JA | 1 |
Gonzáles, S | 1 |
Hess, CW | 1 |
Saunders-Pullman, R | 1 |
Di Giovanni, G | 1 |
Di Matteo, V | 1 |
Pierucci, M | 1 |
Benigno, A | 1 |
Esposito, E | 1 |
Galvan, A | 1 |
Wichmann, T | 1 |
Bishnoi, M | 1 |
Chopra, K | 1 |
Kulkarni, SK | 1 |
Manson, SC | 1 |
Wegner, C | 1 |
Filippi, M | 1 |
Barkhof, F | 1 |
Beckmann, C | 1 |
Ciccarelli, O | 1 |
De Stefano, N | 1 |
Enzinger, C | 1 |
Fazekas, F | 1 |
Agosta, F | 1 |
Gass, A | 1 |
Hirsch, J | 1 |
Johansen-Berg, H | 1 |
Kappos, L | 1 |
Korteweg, T | 1 |
Polman, C | 1 |
Mancini, L | 1 |
Manfredonia, F | 1 |
Marino, S | 1 |
Miller, DH | 1 |
Montalban, X | 1 |
Palace, J | 1 |
Rocca, M | 1 |
Ropele, S | 1 |
Rovira, A | 1 |
Smith, S | 1 |
Thompson, A | 1 |
Thornton, J | 1 |
Yousry, T | 1 |
Frank, JA | 1 |
Matthews, PM | 1 |
Aberg, L | 1 |
Talling, M | 1 |
Härkönen, T | 1 |
Lönnqvist, T | 1 |
Knip, M | 1 |
Alen, R | 1 |
Rantala, H | 1 |
Tyynelä, J | 1 |
Wray, SR | 1 |
Melville, GN | 1 |
Grell, GA | 1 |
Edge, PC | 1 |
Chapman, A | 1 |
Keane, PE | 1 |
Meldrum, BS | 1 |
Simiand, J | 1 |
Vernieres, JC | 1 |
Becker, RE | 1 |
Lal, H | 1 |
Scheel-Krüger, J | 2 |
Gonce, M | 1 |
Schoenen, J | 1 |
Charlier, M | 1 |
Delwaide, PJ | 1 |
Meldrum, B | 1 |
Zivkovic, B | 1 |
Scatton, B | 1 |
Worms, P | 1 |
Lloyd, KG | 1 |
Bartholini, G | 2 |
Ando, K | 1 |
Marsden, CD | 1 |
Sheehy, MP | 1 |
Chesire, RM | 1 |
Cheng, JT | 1 |
Teitelbaum, P | 1 |
Nakamura, S | 1 |
Kameyama, M | 1 |
Rector, WG | 1 |
Herlong, HF | 1 |
Moses, H | 1 |
Kilpatrick, IC | 1 |
Collingridge, GL | 1 |
Starr, MS | 1 |
Izumi, K | 1 |
Munekata, E | 1 |
Yamamoto, H | 1 |
Nakanishi, T | 1 |
Barbeau, A | 2 |
Lesný, I | 1 |
Takamatsu, K | 1 |
Ohta, T | 1 |
Sato, S | 1 |
Sano, A | 1 |
Takahashi, K | 1 |
Murakami, Y | 1 |
Yoshihisa, K | 1 |
Sato, M | 1 |
Ohta, K | 1 |
Spooren, WP | 2 |
Helfrich, SE | 1 |
Cools, AR | 3 |
Weindl, A | 1 |
Kuwert, T | 1 |
Leenders, KL | 1 |
Poremba, M | 1 |
Gräfin von Einsiedel, H | 1 |
Antonini, A | 1 |
Herzog, H | 1 |
Scholz, D | 1 |
Feinendegen, LE | 1 |
Conrad, B | 1 |
Elble, RJ | 1 |
Chaná, P | 1 |
de Marinis, A | 1 |
Barrientos, N | 1 |
Tashiro, Y | 1 |
Drake, JM | 1 |
Chakrabortty, S | 1 |
Hattori, T | 1 |
Richter, A | 1 |
Magnus, L | 1 |
Chadha, A | 1 |
Sur, C | 1 |
Atack, J | 1 |
Duty, S | 1 |
Dostrovsky, JO | 1 |
Lozano, AM | 1 |
Klawans, HL | 1 |
Weiner, WJ | 1 |
Calne, DB | 1 |
Eisler, T | 1 |
Van Rossum, JM | 1 |
Siggins, GR | 1 |
Henriksen, SJ | 1 |
Landis, SC | 1 |
Costall, B | 1 |
Naylor, RJ | 1 |
Owen, RT | 1 |
Di Chiara, G | 1 |
Morelli, M | 1 |
Porceddu, ML | 1 |
Gessa, GL | 1 |
Wolfarth, S | 1 |
Aizawa, H | 1 |
Kwak, S | 1 |
Shimizu, T | 1 |
Mannen, T | 1 |
Shibasaki, H | 1 |
Cuypers, E | 1 |
Larson, AA | 1 |
Hashimoto, M | 1 |
Yokota, A | 1 |
Matsuoka, S | 1 |
Shima, F | 1 |
Matin, MA | 1 |
Hussain, K | 1 |
Cross, AJ | 1 |
Crow, TJ | 1 |
Ferrier, IN | 1 |
Johnson, JA | 1 |
Johnstone, EC | 1 |
Owen, F | 1 |
Owens, DG | 1 |
Poulter, M | 1 |
Sandyk, R | 1 |
Rondot, P | 1 |
Bergmann, KJ | 1 |
Bovier, P | 1 |
Hilleret, H | 1 |
Tissot, R | 1 |
Menza, M | 1 |
Gottlieb, D | 1 |
Shahin, D | 1 |
Stahl, SM | 1 |
Thornton, JE | 1 |
Simpson, ML | 1 |
Berger, PA | 1 |
Napoliello, MJ | 1 |
Tobe, A | 1 |
Egawa, M | 1 |
Saito, K | 1 |
Hashimoto, N | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Modulation of the Activity in the Cerebellum With Transcranial Direct Current Stimulation in Autistic Participants[NCT05781412] | 100 participants (Anticipated) | Interventional | 2022-05-24 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
31 reviews available for gamma-aminobutyric acid and Movement Disorders
Article | Year |
---|---|
Advances in pharmacotherapies for movement disorders in children: current limitations and future progress.
Topics: Amines; Anti-Dyskinesia Agents; Child; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Ami | 2017 |
The pathophysiology of essential tremor and Parkinson's tremor.
Topics: Animals; Electric Stimulation Therapy; Essential Tremor; gamma-Aminobutyric Acid; Humans; Movement D | 2013 |
Imaging the role of GABA in movement disorders.
Topics: Brain; gamma-Aminobutyric Acid; Humans; Movement Disorders; Neuroimaging | 2013 |
[Genome-wide association analyses for neuroleptic-induced tardive dyskinesia].
Topics: Acetylcholine; Animals; Antipsychotic Agents; gamma-Aminobutyric Acid; Genetic Predisposition to Dis | 2011 |
Consensus paper: pathological role of the cerebellum in autism.
Topics: Animals; Autistic Disorder; Cell Adhesion Molecules, Neuronal; Cerebellar Diseases; Cerebellum; Cogn | 2012 |
Striatal microcircuitry and movement disorders.
Topics: Animals; Corpus Striatum; gamma-Aminobutyric Acid; Humans; Movement Disorders; Nerve Net; Receptors, | 2012 |
Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.
Topics: Adaptation, Physiological; Antipsychotic Agents; Corpus Striatum; Excitatory Amino Acid Agents; gamm | 2012 |
[Transcranial magnetic stimulation (TMS) in movement disorders].
Topics: Basal Ganglia; gamma-Aminobutyric Acid; Humans; Motor Cortex; Movement Disorders; Neural Inhibition; | 2001 |
Cannabinoid control of motor function at the basal ganglia.
Topics: Animals; Basal Ganglia; Cannabinoid Receptor Modulators; Cannabinoids; Dopamine; gamma-Aminobutyric | 2005 |
Movement disorders and alcohol misuse.
Topics: Adjuvants, Anesthesia; Alcohol Drinking; Brain; Comorbidity; Dystonic Disorders; Essential Tremor; E | 2006 |
Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?
Topics: Animals; Basal Ganglia Diseases; Central Nervous System; gamma-Aminobutyric Acid; Humans; Movement D | 2006 |
GABAergic circuits in the basal ganglia and movement disorders.
Topics: Animals; Basal Ganglia; GABA Modulators; gamma-Aminobutyric Acid; Humans; Movement Disorders; Neural | 2007 |
Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Topics: Amphetamine; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance | 1981 |
Mechanism of anticonvulsant action of valproate.
Topics: Animals; Aspartic Acid; Cats; Central Nervous System; Epilepsy; gamma-Aminobutyric Acid; Half-Life; | 1982 |
Pharmacological approaches to treatment of hemiballism and hemichorea.
Topics: Acetylcholine; Antipsychotic Agents; Basal Ganglia; Cerebrovascular Disorders; Chorea; Diazepam; Dop | 1983 |
GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Catalepsy; Corpus Striatum; Diencephalon; gam | 1984 |
Pharmacology of GABA.
Topics: 4-Aminobutyrate Transaminase; Anxiety Disorders; Autonomic Nervous System; Barbiturates; Benzodiazep | 1982 |
GABA system, GABA receptor agonists and dyskinesia.
Topics: Basal Ganglia; Cholinergic Fibers; Dopamine; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Huma | 1983 |
[Biogenic amines to the pathophysiology of involuntary movements and cerebellar ataxia (author's transl)].
Topics: Adolescent; Biogenic Amines; Brain; Cerebellar Ataxia; Child; Child, Preschool; Dystonia; gamma-Amin | 1981 |
[Biochemical aspects of involuntary movements (author's transl)].
Topics: Adenosine Triphosphate; Brain; Calcium; Dopamine; gamma-Aminobutyric Acid; Humans; Levodopa; Movemen | 1981 |
Possible involvement of taurine and GABA in morphine-like peptide actions.
Topics: Amino Acids; Analgesia; Animals; Enkephalin, Methionine; gamma-Aminobutyric Acid; Humans; Male; Moto | 1980 |
[Two diabetics with hemichorea-hemiballism and striatal lesions].
Topics: Aged; Chorea; Corpus Striatum; Diabetes Complications; Female; gamma-Aminobutyric Acid; Humans; Magn | 1995 |
Central mechanisms of tremor.
Topics: Basal Ganglia; Cerebellum; Dopamine; gamma-Aminobutyric Acid; Glutamates; Humans; Mesencephalon; Mov | 1996 |
Nonepileptic uses of gabapentin.
Topics: Acetates; Amines; Analgesics; Antimanic Agents; Antiparkinson Agents; Bipolar Disorder; Clinical Tri | 1999 |
Mechanisms of deep brain stimulation.
Topics: Animals; Basal Ganglia; Electric Stimulation Therapy; gamma-Aminobutyric Acid; Humans; Movement Diso | 2002 |
The pharmacology of choreatic movement disorders.
Topics: Acetylcholine; Acute Disease; Amphetamine; Chorea; Dopamine; gamma-Aminobutyric Acid; Hepatolenticul | 1976 |
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopami | 1979 |
Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; Brain; Carbachol; Caudate Nucleus; C | 1976 |
The endogenous opioid system in neurological disorders of the basal ganglia.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clonidine; Endorphins; gamma-Aminobutyric Aci | 1985 |
Progabide: a new GABA-mimetic agent in clinical use.
Topics: Anticonvulsants; Brain Chemistry; Chemical Phenomena; Chemistry; Epilepsy; gamma-Aminobutyric Acid; | 1985 |
The clinical physiology of side effects in long-term L-DOPA therapy.
Topics: Acetylcholine; Basal Ganglia; Brain Chemistry; Brain Stem; Creatinine; Diagnosis, Differential; Dopa | 1974 |
4 trials available for gamma-aminobutyric acid and Movement Disorders
Article | Year |
---|---|
Gabapentin for painful legs and moving toes syndrome.
Topics: Acetates; Aged; Amines; Cyclohexanecarboxylic Acids; Electromyography; Excitatory Amino Acid Antagon | 2004 |
Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis.
Topics: Adolescent; Age Factors; Autoantibodies; Biomarkers; Brain; Child; Dose-Response Relationship, Drug; | 2008 |
GABA and movement disorders.
Topics: Anticonvulsants; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; | 1981 |
Gabapentin and motor fluctuations in Parkinson's disease.
Topics: Acetates; Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Drug Therapy, Combination | 1997 |
48 other studies available for gamma-aminobutyric acid and Movement Disorders
Article | Year |
---|---|
Mice with monoallelic
Topics: Animals; Cerebellum; gamma-Aminobutyric Acid; GTP-Binding Protein alpha Subunits, Gi-Go; Mice; Movem | 2022 |
Exercise enhances motor skill learning by neurotransmitter switching in the adult midbrain.
Topics: Acetylcholine; Animals; Female; gamma-Aminobutyric Acid; Learning; Male; Mesencephalon; Mice, Inbred | 2020 |
Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Cohort Studies; Epilepsy; Female; gamma-Amin | 2018 |
Athetoid Movements as Initial Manifestation of Primary Sjögren Syndrome.
Topics: Aged; Amines; Anticonvulsants; Athetosis; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Ami | 2018 |
The Influence of Primary Motor Cortex Inhibition on Upper Limb Impairment and Function in Chronic Stroke: A Multimodal Study.
Topics: Aged; Aged, 80 and over; Chronic Disease; Electromyography; Evoked Potentials, Motor; Female; gamma- | 2019 |
Sensorimotor cortex gamma-aminobutyric acid concentration correlates with impaired performance in patients with MS.
Topics: Adult; Biomarkers; Female; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Spectroscopy; Male; M | 2013 |
Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice.
Topics: Animals; Antigens; Antigens, Neoplasm; Cell- and Tissue-Based Therapy; Choline O-Acetyltransferase; | 2016 |
[Paroxysmal kinesigenic dyskinesia: a channelopathy? Study of 19 cases].
Topics: Adolescent; Adult; Age of Onset; Amines; Anticonvulsants; Channelopathies; Child; Child, Preschool; | 2009 |
Two novel comments on the treatment of Huntington's disease.
Topics: Basal Ganglia; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Huntington Disease; Models, Neurologi | 2009 |
Hypoglycemia induced behavioural deficit and decreased GABA receptor, CREB expression in the cerebellum of streptozoticin induced diabetic rats.
Topics: Analysis of Variance; Animals; Cerebellum; CREB-Binding Protein; Diabetes Mellitus, Experimental; Di | 2010 |
Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant.
Topics: Action Potentials; Animals; Basal Ganglia; Basal Ganglia Diseases; Dopamine; Efferent Pathways; Fema | 2003 |
The basement membrane components nidogen and type XVIII collagen regulate organization of neuromuscular junctions in Caenorhabditis elegans.
Topics: Alleles; Animals; Basement Membrane; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calciu | 2003 |
Sex differences in GABA(A)ergic system in rat substantia nigra pars reticulata.
Topics: Age Factors; Animals; Cell Count; Female; gamma-Aminobutyric Acid; Immunohistochemistry; In Situ Hyb | 2003 |
[GABOB IN PEDIATRICS. CLINICAL AND ELECTROENCEPHALOGRAPHIC STUDY OF 28 CASES].
Topics: Adolescent; Aminobutyrates; Barbiturates; Brain Injuries; Cerebral Palsy; Child; Electroencephalogra | 1964 |
Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.
Topics: Adult; Aldehyde Oxidoreductases; Amino Acid Metabolism, Inborn Errors; Brain; gamma-Aminobutyric Aci | 2004 |
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Arachidonic Acids; Brain Chemistry; D | 2006 |
Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Topics: Animals; Antipsychotic Agents; Brain Diseases; Control Groups; Disease Models, Animal; Dopamine; Dys | 2008 |
Gamma-aminobutyric acid (GABA), Monograph.
Topics: Anxiety; Depression; Epilepsy; GABA Agents; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives | 2007 |
Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition.
Topics: Adult; Cerebral Cortex; Corpus Callosum; Female; gamma-Aminobutyric Acid; Hand; Humans; Magnetic Res | 2008 |
Successful treatment of hemiballismus with progabide, a new GABA-mimetic agent.
Topics: Aged; Brain; Female; gamma-Aminobutyric Acid; Humans; Movement Disorders; Thalamic Nuclei; Tomograph | 1983 |
Pharmacological and therapeutic actions of GABA receptor agonists.
Topics: Bipolar Disorder; Emotions; gamma-Aminobutyric Acid; Humans; Movement Disorders; Norepinephrine; Rec | 1983 |
Reversal of akinesia and release of festination by morphine or GABA applied focally to the nucleus reticularis tegmenti pontis.
Topics: Animals; Depression, Chemical; gamma-Aminobutyric Acid; Haloperidol; Male; Morphine; Movement Disord | 1984 |
Nonketotic hyperglycemia appearing as choreoathetosis or ballism.
Topics: Aged; Athetosis; Basal Ganglia Diseases; Chorea; Female; gamma-Aminobutyric Acid; Humans; Hyperglyce | 1982 |
Evidence for the participation of nigrotectal gamma-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat.
Topics: Animals; Brain Mapping; Corpus Striatum; gamma-Aminobutyric Acid; Male; Motor Activity; Movement Dis | 1982 |
The subcortical regulatory motor system in the development and its disorders.
Topics: Cerebellum; Child; Child, Preschool; Corpus Striatum; gamma-Aminobutyric Acid; Humans; Infant; Infan | 1980 |
Interactions of the subthalamic nucleus and the subpallidal area in oro-facial dyskinesia: role of GABA and glutamate.
Topics: Animals; Behavior, Animal; Cats; Facial Muscles; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamu | 1995 |
Increased striatal glucose consumption in Sydenham's chorea.
Topics: Adolescent; Aged; Basal Ganglia; Chorea; Corpus Striatum; Diagnosis, Differential; Dopamine; Female; | 1993 |
Functional injury of cholinergic, GABAergic and dopaminergic systems in the basal ganglia of adult rat with kaolin-induced hydrocephalus.
Topics: Acetylcholine; Age Factors; Animals; Cell Count; Choline O-Acetyltransferase; Cholinergic Fibers; Do | 1997 |
Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters.
Topics: Animals; Cricetinae; Disease Models, Animal; Dystonia; Electrophysiology; gamma-Aminobutyric Acid; M | 1999 |
The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat.
Topics: Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; In Vitro Techni | 2000 |
Hemiballismus.
Topics: Aminobutyrates; Diencephalon; gamma-Aminobutyric Acid; Humans; Huntington Disease; Movement Disorder | 1977 |
Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.
Topics: Amphetamines; Animals; Apomorphine; Brain; Cats; Caudate Nucleus; Corpus Striatum; Dopamine; Electro | 1976 |
Electrophysiology of Purkinje neurons in the weaver mouse: iontophoresis of neurotransmitters and cyclic nucleotides, and stimulation of the nucleus locus coeruleus.
Topics: Acetylcholine; Action Potentials; Animals; Cerebral Ventricles; Cyclic AMP; Cyclic GMP; Electrophysi | 1976 |
Gabaminergic and serotonergic modulation of the antidyskinetic effects of tiapride and oxiperomide in the model using 2-(N,N-dipropyl)animo-5,6-dihydroxytetralin.
Topics: 2-Naphthylamine; Aminobutyrates; Animals; Behavior, Animal; Benzamides; Benzimidazoles; Disease Mode | 1978 |
Role of thalamic gamma-aminobutyrate in motor functions: catalepsy and ipsiversive turning after intrathalamic muscimol.
Topics: Animals; Brain Mapping; Catalepsy; Corpus Striatum; gamma-Aminobutyric Acid; Humans; Male; Motor Act | 1979 |
A case of adult onset pure pallidal degeneration. II. Analysis of neurotransmitter markers, with special reference to the termination of pallidothalamic tract in human brain.
Topics: Adult; Aged; Basal Ganglia Diseases; Biomarkers; Brain Chemistry; Choline O-Acetyltransferase; Femal | 1991 |
Oro-facial dyskinesia and the sub-commissural part of the globus pallidus in the cat: role of acetylcholine and its interaction with GABA.
Topics: Acetylcholine; Animals; Behavior, Animal; Carbachol; Cats; Enkephalins; gamma-Aminobutyric Acid; Glo | 1989 |
Intrathecal GABA, glycine, taurine or beta-alanine elicits dyskinetic movements in mice.
Topics: Alanine; Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glycine; Injections, In | 1989 |
[Choreo-ballistic status treated by GABA].
Topics: Child; Chorea; Female; gamma-Aminobutyric Acid; Humans; Movement Disorders | 1989 |
Striatal neurochemical changes and motor dysfunction in mipafox-treated animals.
Topics: Acetylcholinesterase; Animals; Carboxylic Ester Hydrolases; Corpus Striatum; Dopamine; gamma-Aminobu | 1985 |
Chemical and structural changes in the brain in patients with movement disorder.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Antipsychotic Agents; Brain; Choline O-Acetyltransfer | 1985 |
[The electrophysiological approach to tardive dyskinesias].
Topics: Diagnosis, Differential; Dopamine Agents; Dyskinesia, Drug-Induced; Electromyography; gamma-Aminobut | 1988 |
[Progabide treatment of a case of the syndrome of painful legs and moving toes].
Topics: Adult; Female; gamma-Aminobutyric Acid; Humans; Leg; Middle Aged; Movement Disorders; Pain; Receptor | 1985 |
Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.
Topics: Amygdala; Animals; Basal Ganglia; Behavior, Animal; Benzodiazepines; Catalepsy; Corpus Striatum; Dop | 1986 |
A simple model of the interactions of dopamine, acetylcholine and GABA in movement disorders seen in psychiatry.
Topics: Acetylcholine; Basal Ganglia; Dopamine; gamma-Aminobutyric Acid; Humans; Models, Psychological; Move | 1988 |
[Hemiballism and its treatment].
Topics: Cerebrovascular Disorders; Dopamine Antagonists; gamma-Aminobutyric Acid; Humans; Movement Disorders | 1987 |
Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
Topics: Adult; Aged; Aminocaproates; Confusion; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; H | 1985 |
[Effects of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016, bifemelane hydrochloride) on spontaneous motor activity under different experimental conditions].
Topics: Animals; Benzhydryl Compounds; Brain Injuries; gamma-Aminobutyric Acid; Hypoxia, Brain; Male; Metham | 1985 |